Please Wait
Applying Filters...
menu
    • menu
    Inke SA-PSE
    News
    Micronization Enhances Bioavailability in Dry Powder Inhalers

    17 Mar 2026

    // PRESS RELEASE

    APIs for Asthma and COPD: Challenges in Inhalation Formulations

    05 Mar 2026

    // PRESS RELEASE

    Regulatory Pathways for Inhalable APIs in the EU and US

    23 Feb 2026

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Inke RM

    Contact Supplier

    Website

    RDD

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/m-45ySbXUKc?si=ix6_VzdEAx7ufTj2
    Menu

    Inke S.A

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Aclidinium Bromide

    02 1Aprepitant

    03 1Arformoterol Tartrate

    04 1Asenapine Maleate

    05 1Bimatoprost

    06 1Bimatoprost Grenod

    07 1Carvedilol

    08 1Clevidipine Butyrate

    09 1Daprodustat

    10 1Daridorexant

    11 1Eletriptan Hydrobromide

    12 1Enalapril Maleate

    13 1Ensifentrine

    14 1Formoterol Fumarate

    15 1Glycopyrronium Bromide

    16 1Glycopyrronium Tosylate

    17 1Granisetron

    18 1Granisetron Hydrochloride

    19 1Imidapril

    20 1Indacaterol Acetate

    21 1Indacaterol Maleate

    22 1Latanoprost

    23 1Latanoprostene Bunod

    24 1Loratadine

    25 1Mavacamten

    26 1Montelukast Sodium

    27 1Olanzapine

    28 1Olodaterol Hydrochloride

    29 1Ondansetron

    30 1Ondansetron Hydrochloride

    31 1Otilonium Bromide

    32 1Prasugrel

    33 1Prasugrel Hydrochloride

    34 1Quetiapine Hemifumarate

    35 1Revefenacin

    36 1Risperidone

    37 1Rivaroxaban

    38 1Roflumilast

    39 1Rotigotine

    40 1Salmeterol Xinafoate

    41 1Solriamfetol Hydrochloride

    42 1Tafamidis

    43 1Tafamidis Meglumine

    44 1Tafluprost

    45 1Tetrabenazine

    46 1Tiotropium Bromide

    47 1Travoprost

    48 1Umeclidinium Bromide

    49 1Vilanterol Trifenatate

    50 1Zolmitriptan

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Aclidinium Bromide

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on b...
    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Inke Company Banner

    01

    Aclidinium Bromide

    Spain
    arrow
    RDD
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Inke S.A

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas...

    Inke Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Aprepitant

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on b...
    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Inke Company Banner

    02

    Aprepitant

    Spain
    arrow
    RDD
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Inke S.A

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas...

    Inke Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Arformoterol Tartrate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on b...
    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Inke Company Banner

    03

    Arformoterol Tartrate

    Spain
    arrow
    RDD
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Inke S.A

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas...

    Inke Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Asenapine Maleate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on b...
    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Inke Company Banner

    04

    Asenapine Maleate

    Spain
    arrow
    RDD
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Inke S.A

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas...

    Inke Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Bimatoprost

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on b...
    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Inke Company Banner

    05

    Bimatoprost

    Spain
    arrow
    RDD
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Inke S.A

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas...

    Inke Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Bimatoprost Grenod

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on b...
    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Inke Company Banner

    06

    Bimatoprost Grenod

    Spain
    arrow
    RDD
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Inke S.A

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas...

    Inke Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Carvedilol

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on b...
    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Inke Company Banner

    07

    Carvedilol

    Spain
    arrow
    RDD
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Inke S.A

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas...

    Inke Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clevidipine Butyrate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on b...
    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Inke Company Banner

    08

    Clevidipine Butyrate

    Spain
    arrow
    RDD
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Inke S.A

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas...

    Inke Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Daprodustat

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on b...
    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Inke Company Banner

    09

    Daprodustat

    Spain
    arrow
    RDD
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Inke S.A

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas...

    Inke Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Daridorexant

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on b...
    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Inke Company Banner

    10

    Daridorexant

    Spain
    arrow
    RDD
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothInke S.A: APIs manufacturing plant.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Inke S.A

    Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas...

    Inke Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Inke S.a and get a quotation

    Inke S.a is a supplier offers 51 products (APIs, Excipients or Intermediates).

    Find Formoterol Fumarate bulk with DMF, CEP, JDMF offered by Inke S.a

    Find Granisetron Hydrochloride bulk with DMF, CEP, JDMF offered by Inke S.a

    Find Aprepitant bulk with DMF, CEP offered by Inke S.a

    Find Glycopyrronium Bromide bulk with DMF, CEP offered by Inke S.a

    Find Ondansetron Hydrochloride bulk with DMF, CEP offered by Inke S.a

    Find Risperidone bulk with DMF, CEP offered by Inke S.a

    Find Salmeterol Xinafoate bulk with DMF, CEP offered by Inke S.a

    Find Tiotropium Bromide bulk with DMF, CEP offered by Inke S.a

    Find Aclidinium Bromide bulk with DMF offered by Inke S.a

    Find Arformoterol Tartrate bulk with DMF offered by Inke S.a

    Find Carvedilol bulk with JDMF offered by Inke S.a

    Find Clevidipine bulk with DMF offered by Inke S.a

    Find Eletriptan Hydrobromide bulk with JDMF offered by Inke S.a

    Find Enalapril Maleate bulk with CEP offered by Inke S.a

    Find Granisetron bulk with DMF offered by Inke S.a

    Find Indacaterol Maleate bulk with DMF offered by Inke S.a

    Find Latanoprost bulk with DMF offered by Inke S.a

    Find Loratadine bulk with JDMF offered by Inke S.a

    Find Montelukast Sodium bulk with JDMF offered by Inke S.a

    Find Olanzapine bulk with DMF offered by Inke S.a

    Find Olodaterol Hydrochloride bulk with DMF offered by Inke S.a

    Find Ondansetron bulk with DMF offered by Inke S.a

    Find Quetiapine Hemifumarate bulk with JDMF offered by Inke S.a

    Find Revefenacin bulk with DMF offered by Inke S.a

    Find Tetrabenazine bulk with DMF offered by Inke S.a

    Find Travoprost bulk with DMF offered by Inke S.a

    Find Umeclidinium Bromide bulk with DMF offered by Inke S.a

    Find Vilanterol Trifenatate bulk with DMF offered by Inke S.a

    Find Zolmitriptan bulk with DMF offered by Inke S.a

    Find Asenapine Maleate bulk offered by Inke S.a

    Find Bimatoprost bulk offered by Inke S.a

    Find Bimatoprost Grenod bulk offered by Inke S.a

    Find Daprodustat bulk offered by Inke S.a

    Find Daridorexant bulk offered by Inke S.a

    Find Ensifentrine bulk offered by Inke S.a

    Find Glycopyrronium Tosylate bulk offered by Inke S.a

    Find Granisetron Hydrochloride bulk offered by Inke S.a

    Find Imidapril Hydrochloride bulk offered by Inke S.a

    Find Indacaterol Acetate bulk offered by Inke S.a

    Find Latanoprostene Bunod bulk offered by Inke S.a

    Find Mavacamten bulk offered by Inke S.a

    Find Otilonium Bromide bulk offered by Inke S.a

    Find Prasugrel bulk offered by Inke S.a

    Find Prasugrel Hydrochloride bulk offered by Inke S.a

    Find Rivaroxaban bulk offered by Inke S.a

    Find Roflumilast bulk offered by Inke S.a

    Find Rotigotine bulk offered by Inke S.a

    Find Solriamfetol Hydrochloride bulk offered by Inke S.a

    Find Tafamidis bulk offered by Inke S.a

    Find Tafamidis Meglumine bulk offered by Inke S.a

    Find Tafluprost bulk offered by Inke S.a

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.